Celanese Corporation (CE)
Official siteBASIC MATERIALS • CHEMICALS • NYSE
Market Cap: $5.64B
Last updated: Nov 17, 2026 at 11:05 AM ET
Celanese Corporation (CE) Financials: Revenue, Profit and Cash Flow
Celanese reported revenue of $9.54B for the fiscal year ended Dec 31, 2025, down 7.1% from the year before. That year, net income was -$1.15B with a net margin of -12.1%, operating cash flow was $1.15B and free cash flow was $803.00M. The quarter ended Sep 30, 2026 had revenue of $2.56B and net income of $78.00M.
Revenue and Margins
The operating margin was -8.2% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $5.39B, a compound annual rate of 6.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $9.54B | -7.1% | 20.5% | -8.2% | -12.1% |
| Dec 2024 | $10.27B | -6.0% | 22.8% | -7.0% | -14.9% |
| Dec 2023 | $10.93B | +13.0% | 23.6% | 15.2% | 17.8% |
| Dec 2022 | $9.67B | +13.3% | 24.6% | 14.2% | 19.7% |
| Dec 2021 | $8.54B | +51.0% | 31.4% | 22.8% | 22.2% |
| Dec 2020 | $5.66B | -10.2% | 22.9% | 11.7% | 35.2% |
| Dec 2019 | $6.30B | -12.0% | 25.5% | 13.2% | 13.6% |
| Dec 2018 | $7.16B | +16.5% | 27.6% | 18.6% | 17.0% |
| Dec 2017 | $6.14B | +13.9% | 24.6% | 14.0% | 13.8% |
| Dec 2016 | $5.39B | N/A | 26.1% | 17.3% | 16.8% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.54B | $10.27B | $10.93B | $9.67B | $8.54B | $5.66B | $6.30B | $7.16B | $6.14B | $5.39B |
| Cost of revenue | $7.59B | $7.93B | $8.34B | $7.29B | $5.86B | $4.36B | $4.69B | $5.18B | $4.63B | $3.98B |
| Gross profit | $1.95B | $2.34B | $2.58B | $2.38B | $2.68B | $1.29B | $1.61B | $1.97B | $1.51B | $1.41B |
| Research and development | $125.00M | $130.00M | $146.00M | $112.00M | $86.00M | $74.00M | $67.00M | $72.00M | $73.00M | $78.00M |
| Operating income | -$786.00M | -$720.00M | $1.67B | $1.38B | $1.95B | $664.00M | $834.00M | $1.33B | $858.00M | $934.00M |
| Net income | -$1.15B | -$1.53B | $1.95B | $1.90B | $1.90B | $1.99B | $858.00M | $1.21B | $849.00M | $906.00M |
| EBITDA | $17.00M | $160.00M | $2.43B | $1.96B | $2.47B | $1.04B | $1.16B | $1.79B | $1.26B | $1.29B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.56B | $2.75B | $2.34B | $2.20B | $2.42B | $2.53B | $2.39B | $2.36B | $2.65B | $2.65B | $2.61B | $2.56B |
| Gross profit | $539.00M | $618.00M | $468.00M | $420.00M | $521.00M | $534.00M | $474.00M | $522.00M | $619.00M | $641.00M | $554.00M | $593.00M |
| Operating income | $198.00M | $276.00M | $214.00M | $88.00M | -$1.27B | $231.00M | $165.00M | -$1.43B | $245.00M | $250.00M | $210.00M | $237.00M |
| Net income | $78.00M | $129.00M | $48.00M | $17.00M | -$1.35B | $200.00M | -$20.00M | -$1.93B | $117.00M | $153.00M | $124.00M | $684.00M |
Balance Sheet
As of Dec 2025, total debt of $12.60B exceeded cash and equivalents by $11.34B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $21.70B | $22.84B | $26.60B | $26.27B | $11.97B | $10.91B | $9.48B | $9.31B | $1.58B | $8.36B |
| Current assets | $5.69B | $5.13B | $6.22B | $6.61B | $3.81B | $3.76B | $2.77B | $2.87B | $576.00M | $2.47B |
| Cash and equivalents | $1.26B | $962.00M | $1.80B | $1.51B | $536.00M | $955.00M | $463.00M | $439.00M | $576.00M | $638.00M |
| Total liabilities | $17.22B | $17.27B | $19.05B | $20.17B | $7.44B | $7.01B | $6.58B | $5.93B | $0 | $5.34B |
| Short-term debt | $1.20B | $1.50B | $1.38B | $1.31B | $791.00M | $496.00M | $496.00M | $561.00M | $326.00M | $118.00M |
| Long-term debt | $11.39B | $11.08B | $12.30B | $13.37B | $3.18B | $3.23B | $3.41B | $2.97B | $3.31B | $2.89B |
| Shareholder equity | $4.05B | $5.13B | $7.09B | $5.64B | $4.19B | $3.53B | $2.51B | $2.98B | $2.89B | $2.59B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $20.93B | $21.41B | $21.73B | $21.70B | $22.17B | $23.71B | $23.20B | $22.86B | $25.89B | $25.81B | $26.03B | $26.60B |
| Total liabilities | $16.30B | $16.82B | $17.25B | $17.22B | $17.79B | $18.01B | $17.58B | $17.25B | $18.17B | $18.20B | $18.50B | $19.05B |
| Cash and equivalents | $1.36B | $1.36B | $1.76B | $1.26B | $1.44B | $1.17B | $951.00M | $962.00M | $813.00M | $1.19B | $1.48B | $1.80B |
| Shareholder equity | $4.22B | $4.17B | $4.06B | $4.05B | $3.95B | $5.28B | $5.19B | $5.17B | $7.27B | $7.17B | $7.07B | $7.09B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 69.8% of operating cash flow. Dividends came to 5.4% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.15B | $966.00M | $1.90B | $1.82B | $1.76B | $1.34B | $1.45B | $1.56B | $803.00M | $893.00M |
| Capital expenditures | $343.00M | $435.00M | $568.00M | $543.00M | $467.00M | $364.00M | $370.00M | $337.00M | $267.00M | $246.00M |
| Free cash flow | $803.00M | $531.00M | $1.33B | $1.28B | $1.29B | $979.00M | $1.08B | $1.22B | $536.00M | $647.00M |
| Dividends paid | $43.00M | $340.00M | $316.00M | $310.00M | $331.00M | $322.00M | $310.00M | $303.00M | $268.00M | $225.00M |
| Share repurchases | N/A | N/A | N/A | $17.00M | $1.00B | $650.00M | $996.00M | $805.00M | $500.00M | $500.00M |
| Investing cash flow | -$349.00M | -$470.00M | -$134.00M | -$11.14B | -$1.12B | $592.00M | -$493.00M | -$507.00M | -$549.00M | -$439.00M |
| Financing cash flow | -$513.00M | -$1.31B | -$1.46B | $10.29B | -$1.04B | -$1.47B | -$935.00M | -$1.17B | -$351.00M | -$759.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $538.00M | $209.00M | $76.00M | $252.00M | $447.00M | $410.00M | $37.00M | $494.00M | $79.00M | $292.00M | $101.00M | $830.00M |
| Capital expenditures | $69.00M | $62.00M | $66.00M | $84.00M | $64.00M | $93.00M | $102.00M | $105.00M | $88.00M | $105.00M | $137.00M | $128.00M |
| Free cash flow | $469.00M | $147.00M | $10.00M | $168.00M | $383.00M | $317.00M | -$65.00M | $389.00M | -$9.00M | $187.00M | -$36.00M | $702.00M |
Frequently Asked Questions About CE
What is Celanese's annual revenue?
Celanese reported revenue of $9.54B for the fiscal year ended Dec 31, 2025.
How fast is Celanese's revenue growing?
Revenue was down 7.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -0.4%.
Is Celanese profitable?
No. Celanese reported net income of -$1.15B for the fiscal year ended Dec 31, 2025, with a net margin of -12.1%.
How much free cash flow does CE generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.15B minus capital expenditures of $343.00M produced free cash flow of $803.00M.
How much debt does Celanese have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $11.39B, short-term debt of $1.20B and cash and equivalents of $1.26B.
CE pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors